PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical and Experimental Reproductive Medicine10.5653/cerm.2020.042312021483236-244The effect of genistein on insulin resistance, inflammatory factors, lipid profile, and histopathologic indices in rats with polycystic ovary syndromeSasan Amanat, Fatemeh Ashkar, Mohammad Hassan Eftekhari, Nader Tanideh, Saeid Doaei, Maryam Gholamalizadeh, Farhad Koohpeyma, Maral Mokhtarihttp://ecerm.org/upload/pdf/cerm-2020-04231.pdf, http://ecerm.org/journal/view.php?doi=10.5653/cerm.2020.04231, http://ecerm.org/upload/pdf/cerm-2020-04231.pdf
Atherosclerosis10.1016/j.atherosclerosis.2019.06.3982019287e135Lipid Profile In Relation To Antropometric Indices And Insulin Resistance In Overweingt Women With Polycystic Ovary SyndromeA. Atanasova Boshku, D. Ivanova Panovahttps://api.elsevier.com/content/article/PII:S002191501930855X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S002191501930855X?httpAccept=text/plain
Polycystic Ovary Syndrome10.1017/cbo9780511545191.0132001204-214Role of hyperinsulinemic insulin resistance in polycystic ovary syndromeMaria J. Iuornohttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/CF87C451488F5335B34236D7625B87F2
Current Management of Polycystic Ovary Syndrome10.1017/cbo9781107478343.007201063-70Insulin resistance, the metabolic syndrome and polycystic ovary syndromeGerard Conwayhttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/83F05EA19990849A4CAA6AC5174F5445
Polycystic Ovarian Syndrome10.5772/intechopen.907492020Clinical Impact of Insulin Resistance in Women with Polycystic Ovary SyndromeMaria Mitkova Orbetzovahttp://www.intechopen.com/download/pdf/70676
Diabetic Medicine10.1111/j.1464-5491.2011.03460.x201128121445-1454Current perspectives of insulin resistance and polycystic ovary syndromeJ. M. Pauli, N. Raja-Khan, X. Wu, R. S. Legrohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-5491.2011.03460.x, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-5491.2011.03460.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.2011.03460.x/fullpdf
Insulin Resistance and Polycystic Ovarian Syndrome10.1007/978-1-59745-310-3_252007335-348Long-Term Sequelae of Polycystic Ovary SyndromeRichard S. Legrohttp://link.springer.com/content/pdf/10.1007/978-1-59745-310-3_25
Insulin Resistance and Polycystic Ovarian Syndrome10.1007/978-1-59745-310-3_302007397-415Insulin ResistanceRenato Pasquali, Alessandra Gambinerihttp://link.springer.com/content/pdf/10.1007/978-1-59745-310-3_30
Middle East Fertility Society Journal10.1016/j.mefs.2017.11.0022018233178-183The effect of vitamin D3 on improving lipid profile, fasting glucose and insulin resistance in polycystic ovary syndrome women with vitamin D deficiencyHomeira Rashidi, Seyed Bahman Ghaderian, Leila Moradihttps://api.elsevier.com/content/article/PII:S1110569017302406?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1110569017302406?httpAccept=text/plain
Polycystic Ovary Syndrome10.1017/cbo9780511545191.006200165-80Insulin sensitizers in the treatment of polycystic ovary syndromeHelena Teedehttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/2D9B498F2EB79D28DD0C3EFD2A746509